Yaniv Heled

Georgia State University College of Law

Assistant Professor

140 Decatur St.

Atlanta, GA 30303

United States

SCHOLARLY PAPERS

16

DOWNLOADS
Rank 17,431

SSRN RANKINGS

Top 17,431

in Total Papers Downloads

2,500

CITATIONS

1

Scholarly Papers (16)

1.

Patents vs. Statutory Exclusivities in Biological Pharmaceuticals - Do We Really Need Both?

18 Michigan Telecommunications and Technology Law Review 419, Georgia State University College of Law, Legal Studies Research Paper No. 2011-17
Number of pages: 61 Posted: 29 Jun 2011 Last Revised: 21 Feb 2014
Yaniv Heled
Georgia State University College of Law
Downloads 487 (51,883)

Abstract:

Loading...

biologics, pharmaceuticals, patents, statutory exclusivities, market exclusivity, data exclusivity, generics, biologics price competition, hatch, waxman, BPCIA, PPACA, FDA

2.

Intellectual Property and Public Health – A White Paper

Akron Intellectual Property Journal, Vol. 7, 2013, U of Akron Legal Studies Research Paper No. 13-11, Northeastern University School of Law Research Paper No. 152-2013, Seton Hall Public Law Research Paper No. 2259089, Georgia State University College of Law, Legal Studies Research Paper No. 2014-22
Number of pages: 23 Posted: 02 May 2013 Last Revised: 19 Jun 2014
University of New Hampshire School of Law, Michigan State University - College of Law, University of Akron - School of Law, Regent University School of Law, University of Louisville - Louis D. Brandeis School of Law, Georgia State University College of Law, University of Maryland Francis King Carey School of Law, University of Akron - School of Law, University of Akron - School of Law, New York University School of Law, Northeastern University - School of Law, University of Kansas - School of Law and San Francisco Law School
Downloads 456 (56,718)

Abstract:

Loading...

public health, intellectual property, TRIPS, patent, healthcare, health, big data, innovation, health care, pharmaceuticals, alternatives, Hatch-Waxman, prizes, collectively governed systems, clinical trials, black box, transparency, Obamacare, privacy, human rights

3.

Patent Trolls as Parasites

JURIST - Forum, April 2014, Georgia State University College of Law, Legal Studies Research Paper No. 2014-33
Number of pages: 4 Posted: 04 May 2014 Last Revised: 16 Oct 2014
Yaniv Heled
Georgia State University College of Law
Downloads 366 (73,387)

Abstract:

Loading...

4.

Why Primary Patents Covering Biologics Should be Unenforceable Against Generic Applicants under the Biologics Price Competition and Innovation Act

Annals of Health Law, Vol. 21, 2011, Georgia State University College of Law, Legal Studies Research Paper No. 2012-12
Number of pages: 13 Posted: 28 Mar 2012 Last Revised: 30 Jul 2013
Yaniv Heled
Georgia State University College of Law
Downloads 259 (107,674)

Abstract:

Loading...

biologics, pharmaceuticals, Price Competition and Innovation Act, FDA, data exclusivity, exclusivities, patents, Hatch-Waxman, BPCIA, primary patents, secondary patents, PTO, Food and Drug Administration, Patent and Trademark Office, market exclusivity, generic exclusivity

5.

The Regulation of Genetic Aspects of Donated Reproductive Tissue - The Need for Federal Regulation

Columbia Science and Technology Law Review, Vol. 11, 2010
Number of pages: 66 Posted: 14 Aug 2010 Last Revised: 28 Jul 2013
Yaniv Heled
Georgia State University College of Law
Downloads 215 (129,816)

Abstract:

Loading...

sperm, egg, semen, ova, ovum, insemination, IVF, ART, FDA, tissue, donation, gene, genetic disease, DNA, Public Health Service Act, PHSA, biologics, communicable disease, bioethics

6.

On Patenting Human Organisms or How the Abortion Wars Feed into the Ownership Fallacy

Cardozo Law Review, Vol. 36, 2014, Forthcoming, Georgia State University College of Law, Legal Studies Research Paper No. 2014-06
Number of pages: 61 Posted: 30 Mar 2014 Last Revised: 21 May 2014
Yaniv Heled
Georgia State University College of Law
Downloads 196 (141,515)

Abstract:

Loading...

Ownership fallacy, human organism, human being, patents, abortion, Thirteenth Amendment, patenting humans, OTA, Weldon Amendment, directed to or encompassing, chimera, cloning, humanzee, shemale, humouse, innovation, biomedicine, technology

7.

On Presidents, Agencies, and the Stem Cells between Them: A Legal Analysis of President Bush’s and the Federal Government’s Policy on the Funding of Research Involving Human Embryonic Stem Cells

Administrative Law Review, Vol. 60, p. 65, 2008, Georgia State University College of Law, Legal Studies Research Paper
Number of pages: 62 Posted: 15 Jul 2010 Last Revised: 18 Apr 2013
Yaniv Heled
Georgia State University College of Law
Downloads 172 (159,475)
Citation 1

Abstract:

Loading...

8.

Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome’

Genome Medicine, Vol. 6, No. 14, 2014, George Mason Law & Economics Research Paper No. 14-07, San Diego Legal Studies Paper No. 14-148, Loyola-LA Legal Studies Paper No. 2014-19, Georgia State University College of Law, Legal Studies Research Paper No. 2014-16
Number of pages: 4 Posted: 01 Mar 2014 Last Revised: 14 May 2014
West Virginia University College of Law, University of Missouri - Kansas City School of Law, George Mason University - Antonin Scalia Law School, Faculty, University of San Diego School of Law, Villanova University Charles Widger School of Law, University of Utah - S.J. Quinney College of Law, Georgia State University College of Law, University of Baltimore - School of Law and Loyola Law School Los Angeles
Downloads 166 (164,440)

Abstract:

Loading...

gene patents, human genome, Myriad Genetics, patent claims, patent scope

9.

Regulatory Competitive Shelters

76 Ohio St. L.J. 299 (2015), Georgia State University College of Law, Legal Studies Research Paper No. 2015-15
Number of pages: 58 Posted: 26 Apr 2015 Last Revised: 11 Jun 2015
Yaniv Heled
Georgia State University College of Law
Downloads 74 (293,871)

Abstract:

Loading...

Regulatory Competitive Shelters; regulatory exclusivity; data exclusivity; market exclusivity; generic exclusivity; Food and Drug Administration; Environmental Protection Agency; generic; follow-on; patents; innovation

10.

Why Healthcare Companies Should Be(Come) Benefit Corporations

60(1) Boston College Law Review __,2019, Forthcoming, Emory Legal Studies Research Paper
Number of pages: 69 Posted: 05 Jun 2018
Georgia State University College of Law, Emory University School of Law and Georgia State University - College of Law
Downloads 32 (455,321)

Abstract:

Loading...

healthcare, incentives, benefit corporations, pharmaceuticals, public health, healthcare reform, non-profit, for profit, hybrid corporations, non for profit, business entities, corporate form

11.

Biologics, Biosimilars, and Other Idiosyncrasies

Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Bryan Mercurio & Daria Kim, eds. Routledge 2017).
Number of pages: 22 Posted: 18 Apr 2018
Yaniv Heled
Georgia State University College of Law
Downloads 22 (471,181)

Abstract:

Loading...

pharmaceutical, biologic, biosimilar, patent, intellectual property, international intellectual property law, follow-on biologics, international trade agreements

12.

Regulatory Competitive Shelters as Incentives for Innovation in Agrobiotech

2015 Michigan State Law Review 553 , Georgia State University College of Law, Legal Studies Research Paper No. 2015-34
Number of pages: 7 Posted: 06 Nov 2015 Last Revised: 16 Dec 2015
Yaniv Heled
Georgia State University College of Law
Downloads 19 (487,572)

Abstract:

Loading...

Regulatory competitive shelters, RCS, regulatory exclusivities, agrobiotech, FIFRA, Generic Animal Drug and Patent Term Restoration Act, GADPTRA, genetically modified organisms, genetically modified animals, Federal Insecticide, Fungicide and Rodenticide Act, FDA, EPA, exclusivity

13.

Follow-On Biologics Are Set Up to Fail

University of Illinois Law Review, No. 113, 2018
Number of pages: 25 Posted: 26 May 2018
Yaniv Heled
Georgia State University College of Law
Downloads 16 (503,632)

Abstract:

Loading...

biologics, biosimilars, pharmaceuticals, follow-on, generics, innovation, biopharmaceuticals, competition, antitrust

14.

Amicus Curiae Submission on Eli Lily the Company vs. The Government of Canada

Submitted to the ICSID Case No. UNCT14/2
Number of pages: 11 Posted: 22 May 2018
Public Citizen, Northeastern University - School of Law, Loyola University of Chicago School of Law, University of London-School of Oriental and African Studies(SOAS), School of Law, City University London - The City Law School, Georgia State University College of Law and Sciences Po Law School
Downloads 10 (541,672)

Abstract:

Loading...

IP, patent, ISDS, investor-state arbitration, TRIPS, NAFTA, expropriation, fair and equitable treatment, utility, industrial application, promise doctrine, secondary patents, evergreening

15.

Regulatory Competitive Shelters in the Area of Personalized Medicine

Boston University Journal of Science and Technology Law, Vol. 21, No. 2, 287 (2015), Georgia State University College of Law, Legal Studies Research Paper No. 2016-15
Number of pages: 12 Posted: 12 Jul 2016 Last Revised: 22 Oct 2016
Yaniv Heled
Georgia State University College of Law
Downloads 10 (536,420)

Abstract:

Loading...

Regulatory competitive shelters, RCSs, Regulatory exclusivities, personalized medicine, patents, patentability, subject mater eligibility, FDA, innovation

16.

Genetic Paparazzi

Posted: 18 Jul 2014 Last Revised: 14 Feb 2017
Yaniv Heled and Liza Vertinsky
Georgia State University College of Law and Emory University School of Law

Abstract:

Loading...

DNA, genetics, privacy, information, law